Compare LEVI & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEVI | CRL |
|---|---|---|
| Founded | 1853 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 8.0B |
| IPO Year | 2019 | 2000 |
| Metric | LEVI | CRL |
|---|---|---|
| Price | $20.76 | $200.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | $26.23 | ★ $193.17 |
| AVG Volume (30 Days) | ★ 1.7M | 676.0K |
| Earning Date | 01-28-2026 | 02-18-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | ★ 303.84 | N/A |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $6,589,400,000.00 | $4,023,704,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.34 | $1.68 |
| P/E Ratio | $13.94 | ★ N/A |
| Revenue Growth | ★ 11.22 | N/A |
| 52 Week Low | $12.17 | $91.86 |
| 52 Week High | $24.82 | $205.00 |
| Indicator | LEVI | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 63.91 |
| Support Level | $20.94 | $201.04 |
| Resistance Level | $21.28 | $205.00 |
| Average True Range (ATR) | 0.52 | 4.04 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 3.88 | 63.31 |
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.